The Environmental Impact of Biotech and Pharma With My Green Lab
Advances in pharma and biotech are critical for the progression of modern medicine, but at what cost to the environment?
Using data provided by Intercontinental Exchange, My Green Lab – a non-profit organization that aims to build a global culture of sustainability in science – has produced a report providing key insights into the current state of the sector’s carbon emissions.
As an update to My Green Lab’s 2021 study, the report The Carbon Impact of Biotech and Pharma: Collective Action Accelerating Progress to the UN Race to Zero is based on data from 226 publicly listed companies and 147 privately held companies.
In this exclusive video interview with Technology Networks, My Green Lab’s CEO James Connelly discussed why this report is so important, its key findings and steps that laboratories can take to reduce their carbon emissions.